1Koizumi M, Yoshimoto M, Kasumi F, Ogata E. What do breast cancer patientsbenefit from staging bone scintigraphy- Jpn J Clin Oncol. 2001;31(6):263-269.
2Kitchen PRB, Andrews JT, Buckley JD, et al. An analysis of bone scintigraphy inearly (operable) breast cancer. ANZ J Surg. 2008;49(3):313-316.
3Yildiz M, Oral B, Bozkurt M, Cobaner A. Relationship between bone scintigraphyand tumor markers in patients with breast cancer. Ann Nucl Med. 2004;18(6):15-20.
4Jager PL. Bone scintigraphy in oncology. J Postgrad Med [serial online] 2004;50:183-4.
5Kominsky SL, Davidson NE. A "bone" fide predictor of metastasis- Predictingbreast cancer metastasis to bone. J Clin Oncol. 2006;24(15):2227-2229.
6Niccolini A, Carpi A. Postoperative follow up of breast cancer patients: overviewand progress in the use of tumor markers. Tumor Biol. 2000;21:235-248.
7Body JJ, Bartl R, Burckhardt P, Delmas PD, Diel IJ, Fleisch H, et al. Current use ofbisphosphonates in oncology. International Bone and Cancer Study Group. J Clin Oncol.1998;16(12):3890-3899.
8Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Batter G. Metastatic breast cancer:clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer ResTreat. 2000;59:271-278.
9Reginster JY, Henrotin Y, Christiansen C, Gamwell-Henriksen E, Bruyere O,Collette J, et al. Bone resorption in post menopausal women with normal and low BMDassessed with biochemical markers specific for telopeptide derived degradation products ofcollagen type I. Calcif Tissue Int. 2001;69(3):130-137.
10Cicek M, Oursler MJ. Breast cancer bone metastasis and current small therapeutics.Cancer Metastasis Rev. 2006;25(4):635-644.
二级参考文献10
1Soloway M S,Hardenman S W, Hiekey D, et al. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan[J]. Cancer. 1988,61: 195.
2Wymenga L, Boomsma J, Groenier K, et al. Routine bone scans in patients with prostate cancer related to serum prostate specific antigen and alkaline phosphatas[J]. BJU Int, 2001,88(3) : 226.
3O' Dwyer P J,Duffy M J,O' Sullivan F,et al. CEA and CA15-3 in primary and recurrent breast cancer[J].World J Surg, 1990, 14:565.
4Geraghty J G,Coreney E C,Sherry F,et al. CA15-3 in patients with locoregional and metastatic breast carcinoma [ J]. Cancer, 1992, 70:2831.
